Form 8-K - Current report:
SEC Accession No. 0001193125-18-087835
Filing Date
2018-03-19
Accepted
2018-03-19 16:32:55
Documents
1
Period of Report
2018-03-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d537800d8k.htm 8-K 30590
  Complete submission text file 0001193125-18-087835.txt   31761
Mailing Address 501 BOYLSTON STREET SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET SUITE 6102 BOSTON MA 02116 617-482-2333
resTORbio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 18699151
SIC: 2834 Pharmaceutical Preparations